Charles B. Haaser - 15 Feb 2024 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Role
VP Finance and CAO
Signature
/s/ Megan N. Gates, attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Feb 2024
Net transactions value
+$30,000
Form type
4
Filing time
16 Feb 2024, 18:29:16 UTC
Previous filing
14 Feb 2023
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Award $30,000 +100,000 +971% $0.3000 110,302 15 Feb 2024 Direct F1
holding YTEN Common Stock 30,559 15 Feb 2024 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/15/2024 and the remaining 50% on 2/15/2025.
F2 Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.